Now available, Taro-Fingolimod, a generic alternative to Gilenya®
Given the unique requirements of Fingolimod, Taro will be launching the TaroCares® Program to support our product and minimize any disruption to Patients, Physicians, or Pharmacists.
To enroll a patient for support or to schedule first-dose observation please call 1.833.618.0571
Release Date: 
Lundi, novembre 4, 2019



 Taro Corporate
 Taro Corporate Taro U.S.A
 Taro U.S.A Taro Canada
 Taro Canada Taro Israel
 Taro Israel Sun Pharma
 Sun Pharma Chattem Chemicals Inc.
 Chattem Chemicals Inc.


